Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study

Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study

(1) Background: Severe COVID-19 outcomes are associated with cytokine release syndrome, characterized by the release of several immune modulators, including Interleukin-6 (IL-6). Tocilizumab (TCZ) is an IL-6 receptor antagonist used to treat rheumatic arthritis. The study aimed to evaluate the effic...

Full description

Saved in:
Bibliographic Details
Main Authors: Wael Hafez (Author), Mohamad Azzam Ziade (Author), Arun Arya (Author), Husam Saleh (Author), Mahmoud Abdelshakor (Author), Osman Fadl Alla (Author), Pragati Agrawal (Author), Sara Ali (Author), Srinivasa Raghu Rao (Author), Subrata Gupta (Author), Ikram Abdelli (Author), Honeymol Sebastian (Author), Mohamed Ali (Author), Muneir Gador (Author), Ziad Al Baha (Author), Ahmed Abdelrahman (Author)
Format: Book
Published: MDPI AG, 2022-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items